Skelly A - Search Results

1

Dispensing Patterns of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration: A Retrospective Cohort Study in Australia.

Skelly A, Carius HJ, Bezlyak V, Chen FK. Skelly A, et al. Adv Ther. 2017 Dec;34(12):2585-2600. doi: 10.1007/s12325-017-0624-6. Epub 2017 Nov 21. Adv Ther. 2017. PMID: 29164480 Free PMC article.

2

Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.

Nghiem-Buffet S, Baillif S, Regnier S, Skelly A, Yu N, Sodi A. Nghiem-Buffet S, et al. Among authors: skelly a. Eye (Lond). 2017 Apr;31(4):551-559. doi: 10.1038/eye.2016.269. Epub 2016 Dec 2. Eye (Lond). 2017. PMID: 27911446 Free PMC article.

3

A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom.

Johnston RL, Carius HJ, Skelly A, Ferreira A, Milnes F, Mitchell P. Johnston RL, et al. Among authors: skelly a. Adv Ther. 2017 Mar;34(3):703-712. doi: 10.1007/s12325-017-0483-1. Epub 2017 Jan 31. Adv Ther. 2017. PMID: 28144918 Free PMC article.

4

The Clinical Effectiveness of Ranibizumab Treat and Extend Regimen in nAMD: Systematic Review and Network Meta-Analysis.

Danyliv A, Glanville J, McCool R, Ferreira A, Skelly A, Jacob RP. Danyliv A, et al. Among authors: skelly a. Adv Ther. 2017 Mar;34(3):611-619. doi: 10.1007/s12325-017-0484-0. Epub 2017 Feb 10. Adv Ther. 2017. PMID: 28188433 Free PMC article. Review.

5

Erratum to: The Clinical Effectiveness of Ranibizumab Treat and Extend Regimen in nAMD: Systematic Review and Network Meta-Analysis.

Danyliv A, Glanville J, McCool R, Ferreira A, Skelly A, Jacob RP. Danyliv A, et al. Among authors: skelly a. Adv Ther. 2017 May;34(5):1233. doi: 10.1007/s12325-017-0533-8. Adv Ther. 2017. PMID: 28417317 Free PMC article. No abstract available.

6

The economic and humanistic burden of patients in receipt of current available therapies for nAMD.

Jaffe DH, Chan W, Bezlyak V, Skelly A. Jaffe DH, et al. Among authors: skelly a. J Comp Eff Res. 2018 Nov;7(11):1125-1132. doi: 10.2217/cer-2018-0058. Epub 2018 Sep 21. J Comp Eff Res. 2018. PMID: 30238792 Free article.

7

Effectiveness of Continued Ranibizumab Therapy in Neovascular Age-Related Macular Degeneration versus Switch to Aflibercept: Real World Evidence.

Chakravarthy U, Bezlyak V, Sagkriotis A, Griner R, Skelly A, Boyer DS, Milnes F. Chakravarthy U, et al. Among authors: skelly a. Ophthalmol Retina. 2019 Jan;3(1):8-15.e1. doi: 10.1016/j.oret.2018.09.001. Epub 2018 Sep 15. Ophthalmol Retina. 2019. PMID: 30929819 Free article.

8

Treat and Extend Treatment Interval Patterns with Anti-VEGF Therapy in nAMD Patients.

Skelly A, Bezlyak V, Liew G, Kap E, Sagkriotis A. Skelly A, et al. Vision (Basel). 2019 Aug 26;3(3):41. doi: 10.3390/vision3030041. Vision (Basel). 2019. PMID: 31735842 Free PMC article.

9

SIERRA-AMD: A Retrospective, Real-World Evidence Study of Patients with Neovascular Age-Related Macular Degeneration in the United States.

Khanani AM, Skelly A, Bezlyak V, Griner R, Torres LR, Sagkriotis A. Khanani AM, et al. Among authors: skelly a. Ophthalmol Retina. 2020 Feb;4(2):122-133. doi: 10.1016/j.oret.2019.09.009. Epub 2019 Sep 27. Ophthalmol Retina. 2020. PMID: 31812631 Free article.

10

Patient Preferences in the Management of Wet Age-Related Macular Degeneration: A Conjoint Analysis.

Skelly A, Taylor N, Fasser C, Malkowski JP, Goswami P, Downey L. Skelly A, et al. Adv Ther. 2022 Oct;39(10):4808-4820. doi: 10.1007/s12325-022-02248-5. Epub 2022 Aug 22. Adv Ther. 2022. PMID: 35995894 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters